1 May 2024 false No description of principal activity Taxfiler 2024.6 15629447 business:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 15629447 2024-04-30 15629447 2024-05-01 2025-04-30 15629447 business:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 15629447 business:FilletedAccounts 2024-05-01 2025-04-30 15629447 2025-04-30 15629447 business:Director1 2024-05-01 2025-04-30 15629447 business:RegisteredOffice 2024-05-01 2025-04-30 15629447 core:WithinOneYear 2025-04-30 15629447 core:ShareCapital core:PreviouslyStatedAmount 2025-04-30 15629447 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-04-30 15629447 core:PreviouslyStatedAmount 2025-04-30 15629447 business:SmallEntities 2024-05-01 2025-04-30 15629447 countries:EnglandWales 2024-05-01 2025-04-30 15629447 core:PlantMachinery 2024-05-01 2025-04-30 15629447 core:PlantMachinery 2024-04-30 15629447 core:PlantMachinery 2025-04-30 iso4217:GBP xbrli:pure
Company Registration No. 15629447 (England and Wales)
VITAPHARM LTD Unaudited accounts for the year ended 30 April 2025
VITAPHARM LTD Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
VITAPHARM LTD Company Information for the year ended 30 April 2025
Director
Kavita Kaur DHALIWAL
Company Number
15629447 (England and Wales)
Registered Office
167-169 Great Portland Street 5th Floor London London W1W 5PF England
Accountants
Accounts and Returns Ltd 26 Smith St Warwick CV34 4HS
- 3 -
VITAPHARM LTD Statement of financial position as at 30 April 2025
2025
Notes
£
Fixed assets
Tangible assets
4
450
Current assets
Cash at bank and in hand
17,079
Creditors: amounts falling due within one year
5
(9,989)
Net current assets
7,090
Net assets
7,540
Capital and reserves
Called up share capital
1
Profit and loss account
7,539
Shareholders' funds
7,540
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 29 December 2025 and were signed on its behalf by
Kavita Kaur DHALIWAL Director Company Registration No. 15629447
- 4 -
VITAPHARM LTD Notes to the Accounts for the year ended 30 April 2025
1
Statutory information
VITAPHARM LTD is a private company, limited by shares, registered in England and Wales, registration number 15629447. The registered office is 167-169 Great Portland Street, 5th Floor, London, London, W1W 5PF, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% Reducing Balance
4
Tangible fixed assets
Plant & machinery
£
Cost or valuation
At cost
At 1 May 2024
-
Additions
600
At 30 April 2025
600
Depreciation
Charge for the year
150
At 30 April 2025
150
Net book value
At 30 April 2025
450
5
Creditors: amounts falling due within one year
2025
£
Trade creditors
1,052
Taxes and social security
1,780
Loans from directors
7,157
9,989
- 5 -
VITAPHARM LTD Notes to the Accounts for the year ended 30 April 2025
6
Transactions with related parties
During the year, the company received a loan amounting to £7157 from a member of key management personnel. The loan is to be repaid on demand and interest-free. At the balance sheet date, the loan was still outstanding and is presented within creditors: amounts falling due within one year.
7
Average number of employees
During the year the average number of employees was 0.
- 6 -